Its hepatic knockout leads to upregulated activity of the downstream ISR signalling protein, ATF4 and its target genes ASNS, ATF5 and FGF21. Additional results based on further knockout mice models suggested that liver activation of IRS may be a viable target to treat obesity through the upregulation of FGF2167,68. This evidence concerns the gene FGF21 and obesity disorder.